(Sharecast News) - AstraZeneca has struck a deal with the White House to cut drugs prices in America, allowing it to avoid steep tariffs on US imports.
In a statement released on Monday, the Anglo-Swedish blue chip said it will provide direct-to-consumer sales to eligible patients with prescriptions for chronic disease...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE